Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 795-

  Lambert, Marc ^a   Launay, David ^a   Hachulla, Eric ^a   Morell Dubois, Sandrine ^a   Queyrel, Viviane ^a   Hatron, Pierre Yves ^a   Fourrier, François ^b   Soland, Vincent ^c  

^a Faculty of Medicine   (France)

^b UNIV LILLE   (France)

^c CENTRE HOSPITALIER DE VALENCIENNES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 2;

CAPILLARY LEAK SYNDROME; CELL MEMBRANE PERMEABILITY; COMPETITIVE INHIBITION; CYTOKINE RELEASE; DISEASE COURSE; ENDOTHELIUM CELL; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; THERAPY EFFECT;

EID: 67650376929     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181959d09     Document Type: Letter

References (3)

1. Shin JI, Lee JS: Beneficial effect of intravenous immunoglobins on systemic capillary leak syndrome in patients with monoclonal gammopathy. Crit Care Med 2009;37:795
2. Lambert M, Launay D, Hachulla E, et al: High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med 2008; 36:2184-2187
3. Berard JL, Velez RL, Freeman RB, et al: A review of interleukin-2 receptor antagonists in solid organ transplantation. Pharmacotherapy 1999; 19:1127-1137